35th Annual Carrell-Krusen Neuromuscular Symposium
Thursday – Friday, February 14 – 15, 2013
|General Information||Instructional Team|
|Call for Abstracts|
Who Should Attend
The Carrell-Krusen neuromuscular symposium is designed for muscular dystrophy clinic directors, case managers, nurses, and members of interdisciplinary care teams.
At the end of the symposium, participants should be able to:
- Formulate protocols for treatment and management of both common and unusual neuromuscular disorders.
- Identify characteristic findings on muscle biopsies and EMG studies on neuromuscular disorders.
- Describe recent advances in basic and clinical research on neuromuscular disorders.
Concept and Method
The symposium provides an open and energetic interchange to discuss rare and challenging cases, as well as patients with common problems in order to improve their treatment and management. Physical exams will be demonstrated on patients present at the symposium with ample time for discussion of each case.
Sessions will include slide presentations of unusual muscle and nerve biopies and EMG findings presented by several symposium registrants in an informal manner for open discussion. The scientific session will include formal presentations reporting recent research results. The Carrell-Krusen neuromuscular lecture will be a formal one-hour presentation by visiting professor, Charles Thornton, M.D.
This program has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Education through the joint sponsorship of UT Southwestern Medical Center, Children’s Medical Center, and Texas Scottish Rite Hospital for Children. UT Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
Conflict of Interest
It is UT Southwestern’s policy that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed in the course syllabus.
Discussion of Off Label Uses
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be “off-label” uses discussed in the presentations. Speakers have been requested to inform the audience when off-label use is discussed.